8/102 sources · 2 publishersUpdated Nov 3, 11:49 UTC
Evonik reports Q3 2026 loss reduction and 40% adjusted EBITDA growth
Evonik Industries announced that its third‑quarter net loss narrowed to €53 million from €106 million a year earlier, while sales rose 13% to €3.83 billion. Adjusted EBITDA increased 40% year‑over‑year to €629 million. The company also raised its 2026 ROCE target to above 8% and reaffirmed full‑year adjusted EBITDA at the top of its €2.0‑€2.2 billion guidance range.
Why it matters
The sharper loss and higher earnings improve the company’s profitability outlook, which may support the share price and dividend expectations. The upgraded ROCE guidance signals stronger capital efficiency, potentially attracting income‑focused investors.
Key facts
- 1Net loss for Q3 2026 was €53 million, compared with €106 million in the same quarter last year. finance.yahoo.com
- 2Net sales grew 13% year‑over‑year to €3,825 million. investing.com
- 3Adjusted EBITDA reached €629 million, a 40% increase from €448 million in Q3 2025. investing.com
- 4Free cash flow after nine months rose to €601 million, up from €284 million a year earlier. investing.com
- 5ROCE guidance for 2026 was lifted to over 8%, with a target of 11% by 2029. investing.com
- 6Full‑year adjusted EBITDA is expected at the upper end of the €2.0‑€2.2 billion range. finance.yahoo.com
Summary written by AlphAI AI Desk from 2 of 2 sources. Not investment advice. Figures are as stated by the linked sources.